NCT01869660View on ClinicalTrials.gov

Shared Decision Making for Patients With First-admission Schizophrenia

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

23

Participants

Timeline

Start Date

June 30, 2013

Primary Completion Date

April 30, 2015

Study Completion Date

October 31, 2015

Conditions
Schizophrenia
Interventions
BEHAVIORAL

Shared Decision Making

The focus of the SDM is to empower patients to discuss their attitudes and preferences toward treatments.

Trial Locations (1)

Unknown

Numazu Chuou Hospital, Numazu

All Listed Sponsors
lead

Yokohama City University

OTHER

NCT01869660 - Shared Decision Making for Patients With First-admission Schizophrenia | Biotech Hunter | Biotech Hunter